Inhalational Delivery of a JAK3 Inhibitor for the Novel Treatment of Asthma and the Investigation of Pharmaceutical Salts in HFA Propellant Systems
Asthma is a significant lung disease involving chronic inflammation and remodeling of the airways, resulting in reduced quality of life for those who suffer from the condition. Current therapeutic guidelines suggest the use of inhaled corticosteroids for long-term anti-inflammatory relief to manage...
Main Author: | Younis, Usir |
---|---|
Other Authors: | Myrdal, Paul B. |
Language: | en_US |
Published: |
The University of Arizona.
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/626756 http://arizona.openrepository.com/arizona/handle/10150/626756 |
Similar Items
-
The physical chemistry of corticosteroid-cyclodextrin complexes: The Host-guest Chemistry of Corticosteroid and Cyclodextrin Systems Elucidated with NMR and Applied to Novel Surface-decorated Surface Enhanced Raman Spectroscopic Probes
by: Eteer, Shahrazad A.
Published: (2019) -
Inhalatory delirium – the way out
by: Michał Pirożyński
Published: (2015-12-01) -
Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance
by: Darbà J, et al.
Published: (2016-02-01) -
Effectiveness of one-on-one coaching in improving pressurized metered dose inhaler (pMDI) technique among COPD patients: a prospective clinical study
by: Jin Sun Kim, et al.
Published: (2021-08-01) -
Practical, regulatory and clinical considerations for development of inhalation drug products
by: Shuguang Hou, et al.
Published: (2015-12-01)